Egetis Therapeutics AB (publ) (STO:EGTX)

Sweden · Delayed Price · Currency is SEK

6.71

+0.07 (1.05%)

Jul 24, 2026, 4:31 PM CET

Egetis Therapeutics AB Financials Overview

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	63.1	62.4	46.1	57.6	22.6	38.2
Revenue Growth	34.83%	35.36%	-19.96%	154.87%	-40.84%	-6.05%
Gross Profit	8.9	12.4	34.5	46.6	16.3	30.3
Operating Income	-368.2	-339.9	-329.4	-324.8	-198.1	-105.7
Net Income	-279.7	-342.5	-343.6	-326.9	-193.8	-104.5
Earnings Per Share	-0.90	-0.90	-1.10	-1.30	-1.00	-0.60
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Emcitate	63.1	62.3	46.1	57.6	21.9	15.7
Aladote	-	0.1	-	-	-	-
Total	63.1	62.4	46.1	57.6	22.5	38.3

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	142.5	215.8	351	303.3	127.7	144
Total Debt	70.3	76.5	114.2	108.6	0	0
Net Cash (Debt)	72.2	139.3	236.8	194.7	127.7	144
Net Cash Growth	-58.53%	-41.17%	21.62%	52.47%	-11.32%	-49.97%
Net Cash Per Share	0.19	0.37	0.76	0.75	0.66	0.80

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-265.2	-267	-227.9	-278.4	-173.5	-130.1
Capital Expenditures	-1.2	-1.5	-	0	-	-0.2
Free Cash Flow	-266.4	-268.5	-227.9	-278.4	-173.5	-130.3
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	14.10%	19.87%	74.84%	80.90%	72.12%	79.32%
Operating Margin	-583.52%	-544.71%	-714.53%	-563.89%	-876.55%	-276.70%
Pretax Margin	-592.39%	-548.24%	-744.47%	-567.36%	-857.52%	-273.56%
Profit Margin	-403.33%	-547.60%	-743.82%	-567.53%	-857.52%	-273.56%
FCF Margin	-422.19%	-430.29%	-494.36%	-483.33%	-767.70%	-341.10%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	22.61	5.66	5.66	5.66	5.66
PS Ratio	48.93	33.82	54.55	28.34	67.42	29.00